Eydenzelt Q Code: Q5170

Drug & Product Overview

HCPCS Descriptor Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mg

HCPCS Added Date July 1, 2026

Generic Status Single-Source; Branded

About Eydenzelt

Eydenzelt is a medication aligned to the HCPCS Q Code: Q5170 for billing, pricing, and reimbursement purposes in the United States. It is an Ophthalmology drug.

Manufacturers, reach out to us to add more information.

NDC Code Information

No NDC packages are aligned to Q5170 in publicly available CMS files.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
No public NDC alignments

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Aflibercept Biosimilar Information:

Eydenzelt Approval Date: October 2, 2025

Product Name	HCPCS Code	Active Ingredient	BLA Type
Eylea	J0178	Aflibercept	351(a) Originator Product
Opuviz	Q5153	Aflibercept	351(k) Interchangeable
Yesafili	Q5155	Aflibercept	351(k) Interchangeable
Ahzantive	Q5150	Aflibercept	351(k) Interchangeable
Enzeevu	Q5149	Aflibercept	351(k) Interchangeable
Pavblu	Q5147	Aflibercept	351(k) Interchangeable
Eydenzelt	Q5170	Aflibercept	351(k) Biosimilar

One of 6 Eylea biosimilars FDA-approved since 2024 See each approval by month on the BuyandBill.com Pipeline calendar. Comes with Pro. Every aflibercept approval, month by month.

Try a sample month → Open in Pipeline →

Eydenzelt CPT Administration Codes

CPT Code	Description
67028	Intravitreal injection of a pharmacologic agent (separate procedure) 67028

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Eydenzelt Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Osteoporosis in Postmenopausal Women and Men at High Risk of Fracture Glucocorticoid-Induced Osteoporosis Bone Loss in Patients Receiving Hormone Ablation Therapy Prevention of Skeletal-Related Events in Bone Metastases from Solid Tumors Giant Cell Tumor of Bone Hypercalcemia of Malignancy Refractory to Bisphosphonate Therapy

Drug Class

Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]

Frequently Asked Questions

Is there an available Eydenzelt billing and coding guide?

A manufacturer-published billing and coding guide for EYDENZELT was not found.

Are there any available Eydenzelt patient assistance programs?

No manufacturer-published EYDENZELT patient assistance link was found.

Where can I find Eydenzelt prescribing information?

EYDENZELT prescribing information can be found at the link below: Visit Here →

Where can I find Eydenzelt side effect information?

Information regarding EYDENZELT's side effects can be found at MedlinePlus Visit Here →

Does billing EYDENZELT require JZ/JW wastage modifiers?

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.